Platinum complexes as radiosensitizers of hypoxic mammalian cells.
- 1 June 1978
- journal article
- Vol. 3, 98-102
Abstract
Cis-dichlorodiammineplatinum (II), or cis-PDD, has recently been shown to be a potent radiosensitizer of bacteria, particularly under conditions of acute hypoxia. This study extends this observation to include the radiosensitization of mammalian cell (V-79) by low concentrations of cis-PDD, cis-dichlorobis(aziridine) platinum (II), and the trans-isomer of PDD as measured from survival curve analysis. This radiosensitization was obtained at concentrations of 10 micrometer, 60 micrometer, and 100 micrometer for the cis-PDD, aziridine-platinum, and trans-isomer respectively. The corresponding drug toxicity survival levels were 8, 40 and 50%. Dose modification factors of around 1.3 to 1.4 were observed.This publication has 8 references indexed in Scilit:
- Radiation-Induced DNA Damage and Lethality in E. coli As Modified by the Antitumor Agent cis-Dichlorodiammineplatinum(II)Radiation Research, 1977
- Radiation Sensitization of Bacterial Spores by cis-Dichlorodiammineplatinum(II)Radiation Research, 1976
- The effect of combined treatment with a platinum complex and ionizing radiation on chinese hamster ovary cells in vitroBritish Journal of Cancer, 1976
- An Analysis of the Interaction of a Platinum Complex and Radiation with CHO Cells Using the Molecular Theory of Cell SurvivalInternational Journal of Radiation Biology, 1976
- Combination radiotherapy and chemotherapy for P388 lymphocytic leukemia in vivo.1974
- Platinum coordination complexes in cancer chemotherapyThe Science of Nature, 1973
- New platinum complexes with anti-tumour activityChemico-Biological Interactions, 1972
- The Effect of Extreme Hypoxia on Recovery after Radiation by Synchronized Mammalian CellsRadiation Research, 1971